Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 34, Issue 6, Pages 1196-1207
Publisher
Oxford University Press (OUP)
Online
2013-01-26
DOI
10.1093/carcin/bgt033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Pathways: The Role of NR4A Orphan Nuclear Receptors in Cancer
- (2012) H. M. Mohan et al. CLINICAL CANCER RESEARCH
- Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells
- (2011) Yi Huang et al. BREAST CANCER RESEARCH AND TREATMENT
- Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors
- (2011) Kyungsil Yoon et al. CARCINOGENESIS
- Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study
- (2010) Anne M. Traynor et al. Journal of Thoracic Oncology
- Histone Demethylase LSD1 Regulates Neural Stem Cell Proliferation
- (2010) G. Sun et al. MOLECULAR AND CELLULAR BIOLOGY
- Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
- (2009) Soyoung Lim et al. CARCINOGENESIS
- Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes
- (2009) Y. Huang et al. CLINICAL CANCER RESEARCH
- Novel Structural Insights into Class I and II Histone Deacetylases
- (2009) Ralf Ficner CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Polyamine analogues targeting epigenetic gene regulation
- (2009) Yi Huang et al. Essays in Biochemistry
- RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling
- (2009) Genqing Liang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer
- (2008) P. Novak et al. CANCER RESEARCH
- A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
- (2008) T. H. Luu et al. CLINICAL CANCER RESEARCH
- Histone deacetylase inhibitors in cancer therapy
- (2008) Min-Jung Lee et al. CURRENT OPINION IN ONCOLOGY
- A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas
- (2008) Emilia Wiechec et al. GENES CHROMOSOMES & CANCER
- A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2008) Susan C. Modesitt et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now